Mortality and health care burden of Budd Chiari syndrome in the United States: A nationwide analysis (1998-2017)

Table 5 Multivariate model on total charges

	Response	Estimate	Standard error	P value for beta	P value for type 3 test
Race	1: White (reference)	0.000	-	-	< 0.0001
	2: Black	-0.037	0.026	0.162
	3: Hispanic	0.015	0.031	0.613
	4: Asian/Pacific Islander	0.136	0.058	0.019
	6: Other	0.082	0.046	0.077
	9: Unknown	-0.185	0.025	< 0.0001
Hospital bed size	1: Small (reference)	0.000	-	-	< 0.0001
	2: Medium	0.080	0.034	0.018
	3: Large	0.169	0.029	< 0.0001
Hospital location and teaching status	1: Rural (reference)	0.000	-	-	< 0.0001
	2: Urban nonteaching	0.428	0.037	< 0.0001
	3: Urban teaching	0.552	0.034	< 0.0001
Hospital region	1: Northeast	-0.195	0.027	< 0.0001	< 0.0001
	2: Midwest	-0.333	0.027	< 0.0001
	3: South	-0.330	0.024	< 0.0001
	4: West (reference)	0.000	-	-
Complications
Acute liver failure	Yes (reference = No)	0.078	0.039	0.044	0.044
Acute respiratory Failure	Yes (reference = No)	0.204	0.036	< 0.0001	< 0.0001
Acute kidney injury	Yes (reference = No)	0.146	0.025	< 0.0001	< 0.0001
Hepatorenal syndrome	Yes (reference = No)	-0.132	0.050	0.008	0.009
IVC thrombosis	Yes (reference = No)	0.075	0.035	0.035	0.035
Acute blood loss anemia/ hemorrhagic	Yes (reference = No)	0.155	0.035	< 0.0001	< 0.0001
Cancer	Yes (reference = No)	-0.052	0.025	0.037	0.037
Elixhauser Comoridity Score excluding liver disease		0.005	0.001	< 0.0001	< 0.0001
Other variables
Number of procedures		0.118	0.004	< 0.0001	< 0.0001
Length of stay		0.054	0.001	< 0.0001	< 0.0001

IVC: Inferior vena cava.